Advanced Practice Nursing Issues

Epstein-Barr Virus Infection and Lymphoproliferative Disorder After Hematopoietic Cell Transplantation

Yazhen Zhong

lymphoma, hematopoietic cell growth factor
CJON 2012, 16(2), 211-214. DOI: 10.1188/12.CJON.211-214

Common herpes viruses such as Epstein-Barr virus (EBV) cause infection and disease after hematopoietic cell transplantation (HCT). Post-transplantation lymphoproliferative disorder following allogeneic HCT is a rare but life-threatening disease, mostly associated with EBV-infected B cells. Anti-CD20 monoclonal antibodies (e.g., rituximab) target normal and infected B cells and further suppress the patient's immune system. This article describes the development of cellular therapies by infusing virus-specific cytotoxic T lymphocytes via IV into patients to create an adoptive immune system for specific viral suppression.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.